IL156774A0 - Inhibitors of cruzipain and other cysteine proteases - Google Patents

Inhibitors of cruzipain and other cysteine proteases

Info

Publication number
IL156774A0
IL156774A0 IL15677402A IL15677402A IL156774A0 IL 156774 A0 IL156774 A0 IL 156774A0 IL 15677402 A IL15677402 A IL 15677402A IL 15677402 A IL15677402 A IL 15677402A IL 156774 A0 IL156774 A0 IL 156774A0
Authority
IL
Israel
Prior art keywords
inhibitors
cruzipain
cysteine proteases
general formula
compounds
Prior art date
Application number
IL15677402A
Other languages
English (en)
Original Assignee
Amura Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0101179A external-priority patent/GB0101179D0/en
Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd
Publication of IL156774A0 publication Critical patent/IL156774A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL15677402A 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases IL156774A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0101179A GB0101179D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27535901P 2001-03-13 2001-03-13
PCT/GB2002/000184 WO2002057270A1 (fr) 2001-01-17 2002-01-17 Inhibiteurs de la cruzipaine et autres cysteines proteases

Publications (1)

Publication Number Publication Date
IL156774A0 true IL156774A0 (en) 2004-02-08

Family

ID=26245571

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15677402A IL156774A0 (en) 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases
IL156774A IL156774A (en) 2001-01-17 2003-07-03 Inhibitors of crucifine and other cysteine proteases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156774A IL156774A (en) 2001-01-17 2003-07-03 Inhibitors of crucifine and other cysteine proteases

Country Status (21)

Country Link
US (2) US7425562B2 (fr)
EP (1) EP1362052B1 (fr)
JP (1) JP4608183B2 (fr)
KR (1) KR100860067B1 (fr)
CN (1) CN1269822C (fr)
AT (1) ATE356130T1 (fr)
AU (1) AU2002219397B2 (fr)
BR (1) BR0206501A (fr)
CA (1) CA2436462C (fr)
CY (1) CY1106640T1 (fr)
DE (1) DE60218633T2 (fr)
DK (1) DK1362052T3 (fr)
ES (1) ES2281516T3 (fr)
HK (1) HK1060729A1 (fr)
IL (2) IL156774A0 (fr)
MX (1) MXPA03006224A (fr)
NO (1) NO328208B1 (fr)
NZ (1) NZ526913A (fr)
PT (1) PT1362052E (fr)
RU (1) RU2329266C2 (fr)
WO (1) WO2002057270A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
IL156577A0 (en) 2000-12-22 2004-01-04 Axys Pharm Inc Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
BR0212535A (pt) 2001-09-14 2004-10-19 Aventis Pharma Inc Compostos e composições como inibidores de catepsina
CN1324018C (zh) 2001-11-14 2007-07-04 安万特药物公司 作为组织蛋白酶s抑制剂的寡肽以及含有它们的组合物
CN100354276C (zh) * 2002-07-16 2007-12-12 阿姆拉医疗有限公司 生物活性化合物
US7399765B2 (en) * 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
BRPI0506719A (pt) * 2004-01-08 2007-05-02 Medivir Ab composto, composição farmacêutica, e, uso de um composto
JP2005350417A (ja) * 2004-06-11 2005-12-22 Dai Ichi Seiyaku Co Ltd 還元的エーテル化法を用いたピロリジン誘導体の製造法
PT1865940E (pt) * 2005-03-21 2013-04-08 Virobay Inc Compostos alfa-cetoamida como inibidores de proteases de cisteína
GB0513840D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0513839D0 (en) * 2005-07-07 2005-08-10 Medivir Ab Cysteine protease inhibitors
GB0614052D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614037D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614046D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614073D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614053D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
WO2008114054A1 (fr) * 2007-03-19 2008-09-25 Medivir Ab Inhibiteurs de protéase
US7893067B2 (en) 2007-06-27 2011-02-22 Medivir Ab Cysteine protease inhibitors
WO2009087379A2 (fr) * 2008-01-09 2009-07-16 Amura Therapeutics Limited Composés
GB0804701D0 (en) 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
GB0804702D0 (en) * 2008-03-13 2008-04-16 Amura Therapeutics Ltd Compounds
EP2665708A4 (fr) * 2011-01-20 2014-07-09 Univ Colorado Regents Modulateurs du complexe tlr3/arnds et leurs utilisations
JP6218734B2 (ja) * 2012-08-30 2017-10-25 国立大学法人 東京大学 内部寄生虫防除剤
CN106279188A (zh) * 2016-07-21 2017-01-04 青岛科技大学 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) * 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
EP0923535A4 (fr) 1996-08-28 2001-01-10 Smithkline Beecham Corp Inhibiteurs de cysteine protease
WO1998028268A2 (fr) 1996-12-23 1998-07-02 Elan Pharmaceuticals, Inc. CYCLOALKYLE, LACTAME ET COMPOSES ASSOCIES, COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES, ET PROCEDES D'INHIBITION DE LA LIBERATION DU PEPTIDE β-AMYLOIDE ET/OU DE SA SYNTHESE AU MOYEN DE TELS COMPOSES
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
GB9911417D0 (en) * 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
EP1345931A2 (fr) 2000-11-17 2003-09-24 Medivir UK Ltd Inhibiteurs de cysteine protease
IL156577A0 (en) 2000-12-22 2004-01-04 Axys Pharm Inc Selective cathepsin s inhibitors and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CN1269822C (zh) 2006-08-16
AU2002219397B2 (en) 2008-02-14
EP1362052B1 (fr) 2007-03-07
JP2004518674A (ja) 2004-06-24
US7425562B2 (en) 2008-09-16
RU2329266C2 (ru) 2008-07-20
CA2436462C (fr) 2011-07-05
RU2003125270A (ru) 2005-02-20
ES2281516T3 (es) 2007-10-01
DK1362052T3 (da) 2007-07-09
CA2436462A1 (fr) 2002-07-25
US20040138250A1 (en) 2004-07-15
NO20033220L (no) 2003-09-17
PT1362052E (pt) 2007-04-30
KR20030075161A (ko) 2003-09-22
HK1060729A1 (en) 2004-08-20
DE60218633D1 (de) 2007-04-19
EP1362052A1 (fr) 2003-11-19
ATE356130T1 (de) 2007-03-15
NO328208B1 (no) 2010-01-11
CY1106640T1 (el) 2012-01-25
WO2002057270A1 (fr) 2002-07-25
DE60218633T2 (de) 2008-02-21
CN1486320A (zh) 2004-03-31
BR0206501A (pt) 2004-01-13
IL156774A (en) 2008-08-07
US20090247471A1 (en) 2009-10-01
MXPA03006224A (es) 2004-10-15
KR100860067B1 (ko) 2008-09-24
JP4608183B2 (ja) 2011-01-05
NZ526913A (en) 2004-12-24
NO20033220D0 (no) 2003-07-16

Similar Documents

Publication Publication Date Title
IL156774A0 (en) Inhibitors of cruzipain and other cysteine proteases
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
UA74372C2 (uk) Інгібітори серинових протеаз, фармацевтична композиція на їх основі
SE0201976D0 (sv) Novel compounds
BR0215405A (pt) Composições e processos de uso de collajolie
DE60112974D1 (en) Carbolinderivate
DK1200418T3 (da) Nematodicide trifluorbutener
DE60216233D1 (en) Carbolinderivate
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
SE0101932D0 (sv) Pharmaceutical combinations
AU2220702A (en) Serine protease inhibitors
AU2001264065A1 (en) Serine protease inhibitors
AU2001264081A1 (en) Serine protease inhibitors
MXPA04006041A (es) Antivirales de piridoquinoxalina.
SE0101038D0 (sv) Novel compounds
SE0003476D0 (sv) Compounds
UA83266C2 (en) Oxazole derivatives of tetracyclines
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
DK1204659T3 (da) Serotonerge benzofuraner
WO2002057246A3 (fr) Inhibiteurs de la cruzipaine et d'autres cysteines proteases
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
WO2002057248A3 (fr) Inhibiteurs de la cruzipain et autres cysteine proteases
ATE269313T1 (de) Tryptase-inhibitoren
UA85994C2 (en) N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed